Selection of w and w* [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2018-04-26 11:51 (2189 d 02:48 ago) – Posting: # 18733
Views: 16,133

Dear Detlew,

❝ Defining the weights that way is IMHO not what you intended.


OK, I see!

❝ BTW: Choosing the weights "optimal" is for me a mystery. To do that, we had to know the outcomes of the two stages, but we don't have them until the study has been done. On the other hand we have to predefine them to gain strict TIE control. Hier beißt sich die Katze in den Schwanz.


Using the median of n.tot to define the weights from the sim’s was a – maybe too naïve – attempt. Other suggestions? Some regulatory statisticians prefer the first stage in a TSD to be like in a fixed sample design. For some combinations of n1/CV in my grid this will be ≤ the median of n.tot. In other words, I’m not too optimistic but rather too pessimistic. Now what?
Example: CV 0.1, GMR 0.95, target power 0.80. Fixed sample design’s n 8 (n1 ⇒ 12 acc. to GLs). n.mean and median of n.tot 12 with the default weights (0.5, 0.25). Even the 95% percentile of n.tot is 12.
:confused:

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,646 registered users;
57 visitors (1 registered, 56 guests [including 7 identified bots]).
Forum time: 14:39 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5